Phoenix House Founder Attends Ditchley Conference on Drug War

Friday, December 7th, 2012

Honorable Gil Kerlikowske, Director of Office of National Drug Control Policy, and Dr. Mitchell S. Rosenthal, Founder of Phoenix HouseThis weekend, Phoenix House Founder Mitchell S. Rosenthal, M.D. is attending a transatlantic conference debating a new approach to the War on Drugs. The conference, held December 6-8 and hosted by the UK-based Ditchley Foundation, centers around the question: “How should drug control policy change?”

Dr. Rosenthal and the other participants will examine trends in drug consumption, the factors behind those trends, the success and failures of current policies, and better alternatives. Much of the debate will focus on reducing demand for drugs and fostering international cooperation to address drug use.

The conference’s plenary speakers included Daniela Spinant, Head of the Anti-Drugs Policy Unit with the European Commission, and Gil Kerlikowske, Director of the Office of National Drug Control Policy (pictured above left with Dr. Rosenthal). The conference participants are divided into three working groups, which will each debate a different facet of the topic and then present a report to all the conference participants.

Ditchley Foundation, founded as a “a venue for strengthening the transatlantic dialogue” between Great Britain and the United States, has hosted over 1,000 conferences and just celebrated “50 years of transatlantic and global dialogue.” The conference center is a country house in Oxfordshire and was donated to the Ditchley Foundation by Sir David Wills. During the 1930s and 1940s, the estate hosted Sir Winston Churchill and other British leaders.

We’re proud that Dr. Rosenthal, who has years of rich experience in caring for those who struggle with substance abuse, can represent Phoenix House in a discussion on how to better help and prevent addiction.

Share this page: Print this page:

Comments are closed.